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Recently, the use of Christia vespertilionis (L.) Bakh. f. decoction as 
anti-cancer agent has gained a lot of attention in Malaysia as an 
alternative medicine to the modern treatment [1]. This plant has 
been distributed and formulated as tea throughout Malaysia by 
traditional practitioners. It has gained a huge popularity among 
Malaysians, not only the cancer patient’s but researchers in Malaysia 
to discover the real potential of this plant. Christia vespertilionis is an 
ornamental plant Fabaceae and it is known as red butterfly wing, 
island peak, mariposa (butterfly in Spanish) or rerama which means 
butterfly in Malaysia (fig. 1). This plant is widespread in tropical 
Southeast Asia and it is assumed to be native to Cambodia, Thailand, 
Vietnam, China, Indonesia, Myanmar and Malaysia. In traditional 
medicine, this plant is believed to treat snake bites, tuberculosis, heal 
bone fractures, increase blood circulation, bronchitis and cold [2, 3]. 
 
 
Fig. 1: Christia vespertilionis (L.) Bakh. f., commonly known as 
the red butterfly wing 
 
An early study to highlight the potential of C. vespertilionis with a 
focus on its pharmacology properties was conducted by Nguyen-
Pouplin et al. [3]. Cyclohexane extract of the whole plant was 
reported to have anti plasmodial activity towards Plasmodium 
falciparum FCB1 with IC50
The aqueous methanolic stem was found to be the most potent and 
active towards P. falciparum NF-54. In-vitro assay showed 87.8% 
suppression of parasitaemia compared to control and fifteen 
metabolites was able to be isolated from this wonder plant. 
 value of 10.8 µg/ml. The study also 
discovered high cytotoxicity against two different mammalian cell 
lines (Hela and MRC5) with a selectivity index of less than two [3]. 
Christia vespertilionis was further studied as anti plasmodial agent, 
in-vitro and in-vivo. An anti plasmodial assay was carried out and 
bioassay-guided studies were applied to characterize the active 
compound from this plant [4].  
Hofer et al. [5] conducted a study with a focus on neuroendocrine 
tumours. These tumours are known for their poor response to both 
radiation and standard chemotherapy, thus surgical removal is 
currently the most effective treatment. This study focused on the 
effects of Christia vespertilionis on human medullary thyroid 
carcinoma and human intestinal neuroendocrine tumours. It was 
found that ethyl acetate extracts of this magnificent plant have high 
inhibition of cancer cells whilst not affecting normal human 
fibroblasts. These extracts also caused a change of gene expression 
in both of the carcinomas and tumours. The results imply a great 
potential of use for Christia vespertilionis against cancer. 
To our best knowledge, there is no comprehensive evidence 
concerning the phytochemistry, pharmacology and toxicology of this 
plant. Further studies on C. vespertilionis should be performed, 
especially concerning the toxicology of this plant. Safety assessments 
and clinical trials should be conducted before it can be integrated 
into medicinal practices.  
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